Company Dossier · Health Care
Stryker Corporation
- S&P 500
- Russell 1000
What Stryker Corporation is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $25.8 billion, up 8.5% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $4.70 billion, up 17% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $0.82 billion, up 11% from a year earlier.SEC EDGAR filings (XBRL)
- Long-term debt issued in the fiscal year to December 31, 2025: $2.98 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (July 30, 2026): sentiment 0.60 on a −1 to +1 scale (mixed), confidence 0.80 of 1.Palanor Discourse
- Guidance in the last 90 days: 2 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
- Latest annual report (filed February 11, 2026): 26 risk factors added, 3 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $118 million on the open market.SEC Form 4
- 2,269 institutional managers reported a position at June 30, 2026 (−44 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 26 (43 a year earlier).U.S. Department of Labor (OFLC)
Risk events (12 months): 1 — latest OSHA inspection, Aug 18, 2026 →
Company Posture
How Company Posture is measured →What Stryker Corporation is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Steady · Mixed
Expanding ↔ Retrenching
Steady
- Capital spending59th pct
- Debt raised15th pct
- Buybacks vs capex—
- Hiring filings64th pct
- Deals and private raises40th pct
- Patent publications36th pct
Confident ↔ Hedging
Mixed
- Call sentiment36th pct
- Call confidence39th pct
- Guidance changes92nd pct
- Risk factors added—
- Insider open-market trades89th pct
- + Guidance changes
- + Insider open-market trades
- − Call sentiment
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver70th pct
- Stress filings48th pct
Credit
How these are built →Stryker Corporation's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$14.9B
- Due within a year $0.8B
- Longer term $14.2B
- Default point $7.8B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
| Priced | Amount | Coupon | Matures | Spread | Yield |
|---|---|---|---|---|---|
| Jan 30, 2025 | $1B | 5.200% | 2035 (10y) | +73bp | 5.236% |
| Jan 30, 2025 | $500M | 4.550% | 2027 (2y) | +38bp | 4.594% |
| Jan 30, 2025 | $700M | 4.700% | 2028 (3y) | +48bp | 4.724% |
| Jan 30, 2025 | $800M | 4.850% | 2030 (5y) | +58bp | 4.890% |
| Sep 4, 2024 | $750M | 4.625% | 2034 (10y) | +92bp | 4.692% |
| Sep 4, 2024 | €600M | 3.625% | 2036 (12y) | +142bp | 3.729% |
| Sep 4, 2024 | €800M | 3.375% | 2032 (8y) | +132bp | 3.424% |
| Sep 4, 2024 | $750M | 4.250% | 2029 (5y) | +72bp | 4.297% |
| Dec 6, 2023 | €600M | 3.375% | 2028 (5y) | +121bp | 3.375% |
| Dec 5, 2023 | $600M | 4.850% | 2028 (5y) | +73bp | 4.872% |
From the pricing term sheets Stryker Corporation filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name Stryker Corporation, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralStryker (SYK) Is Changing CEOs After the Stock Fell 25% Over Twelve Months
insidermonkey.com · via Marketaux · Oct 9, 2026
- NeutralStryker, Abbott among new Overweights at Barclays (SYK:NYSE)
seekingalpha.com · via Marketaux · Oct 7, 2026
- NeutralStryker: This Dividend Aristocrat Is Finally Cheap Again (NYSE:SYK)
seekingalpha.com · via Marketaux · Oct 5, 2026
- Positive
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (THORN RUN PARTNERS)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (DCI GROUP, L.L.C.)third_quarter 2026 · $0.0 million
- Oct 20, 2026LobbyingLobbying report (DCI GROUP, L.L.C.)third_quarter 2026
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 20, 2026Patent
- Oct 19, 2026LobbyingLobbying report (BAKER & HOSTETLER LLP)third_quarter 2026 · $0.1 million
- Oct 13, 2026LobbyingLobbying report (DCI GROUP, L.L.C.)third_quarter 2026
- Oct 6, 20268-KDirector or officer changeItem 5.02
- Aug 18, 2026Risk event
- Jul 20, 2026LobbyingLobbying report (STRYKER CORPORATION)second_quarter 2026 · $0.3 million
- Jul 20, 2026LobbyingLobbying report (BGR GOVERNMENT AFFAIRS)second_quarter 2026 · $0.1 million
- May 20, 20268-KDirector or officer changeItem 5.02
- May 8, 20268-KShareholder vote resultsItem 5.07
- Apr 9, 20268-KCybersecurity incidentItem 1.05
- Feb 11, 202610-KAnnual report (10-K)26 risk factors added, 3 removed
- Dec 4, 20258-KDirector or officer changeItem 5.02
- May 13, 20258-KDirector or officer changeItem 5.02
- May 13, 20258-KShareholder vote resultsItem 5.07
- Feb 27, 20258-KMaterial agreement signedItem 1.01
- Feb 19, 20258-KAcquisition or sale completedItem 2.01
- Feb 12, 202510-K
- Feb 10, 20258-KMaterial agreement signedItem 1.01
- Feb 10, 20258-KDirector or officer changeItem 5.02
- Jan 28, 20258-KDirector or officer changeItem 5.02
- Jan 7, 20258-KMaterial agreement signedItem 1.01
- Feb 14, 202410-K
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Becton Dickinson BDX | $22.5B | $2.7B | Jun 30, 2026 |
| Boston Scientific BSX | $21.0B | $3.6B | Jun 30, 2026 |
| GE HealthCare GEHC | $21.0B | — | Mar 31, 2026 |
| Medtronic MDT | $37.5B | $6.1B | Jul 31, 2026 |
| Baxter International BAX | $11.5B | — | Jun 30, 2026 |
| Intuitive Surgical ISRG | $11.0B | $3.2B | Jun 30, 2026 |
| Zimmer Biomet ZBH | $8.5B | $1.5B | Jun 30, 2026 |
| Edwards Lifesciences EW | $6.5B | $1.4B | Jun 30, 2026 |